SWOG clinical trial number
SWOG-7419

VP-16-213(4' Dm Methyl-Epipodophy LL-toxin-B-D Ethylidene Glucoside) in Adults with Metastatic Malignant Melanoma

Closed
Phase
II
Abbreviated Title
VP-16-213(4' Dm Methyl-Epipodophy LL-toxin-B-D Ethylidene Glucoside) in Adults with Metastatic Malignant Melanoma
Activated
08/23/1974
Closed
05/19/1975

Research committees

Melanoma

Other Clinical Trials

SWOG Clinical Trial Number
S1801